ArticleTranslational oncology2025

m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway.

Tinghui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.